Compile Data Set for Download or QSAR
Report error Found 10 Enz. Inhib. hit(s) with all data for entry = 6820
TargetCalcium release-activated calcium channel protein 1(Human)
Rhizen Pharmaceuticals

US Patent
LigandPNGBDBM152937(US8993612, 20)
Affinity DataIC50: 39.2nMT: 2°CAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
Go to US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Rhizen Pharmaceuticals

US Patent
LigandPNGBDBM152932(US8993612, 6)
Affinity DataIC50: 51.3nMT: 2°CAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
Go to US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Rhizen Pharmaceuticals

US Patent
LigandPNGBDBM152936(US8993612, 18)
Affinity DataIC50: 53.4nMT: 2°CAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
Go to US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Rhizen Pharmaceuticals

US Patent
LigandPNGBDBM152935(US8993612, 17)
Affinity DataIC50: 86.1nMT: 2°CAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
Go to US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Rhizen Pharmaceuticals

US Patent
LigandPNGBDBM152938(US8993612, 21)
Affinity DataIC50: 139nMT: 2°CAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
Go to US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Rhizen Pharmaceuticals

US Patent
LigandPNGBDBM152933(US8993612, 10)
Affinity DataIC50: 147nMT: 2°CAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
Go to US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Rhizen Pharmaceuticals

US Patent
LigandPNGBDBM152939(US8993612, 30)
Affinity DataIC50: 161nMT: 2°CAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
Go to US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Rhizen Pharmaceuticals

US Patent
LigandPNGBDBM152930(US8993612, 2)
Affinity DataIC50: 183nMT: 2°CAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
Go to US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Rhizen Pharmaceuticals

US Patent
LigandPNGBDBM152934(US8993612, 12)
Affinity DataIC50: 263nMT: 2°CAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
Go to US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Rhizen Pharmaceuticals

US Patent
LigandPNGBDBM152931(US8993612, 5)
Affinity DataIC50: 383nMT: 2°CAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/28/2015
Entry Details
Go to US Patent